Assessment and monitoring of biologic drug adverse events in patients with psoriasis
Tessa Hanley, Marc Handford, Dawn Lavery, Zenas ZN Yiu Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, UKBackground: Current treatment guidelines for biologic therapies in psoriasis differ in their recommendation for the monitoring of adverse events.Objective: The aim of this pap...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f31746f798074739988f79dc90dc4482 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!